Erythropoitein increases in vitro motility and vitality of human spermatozoa

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: Erythropoietin and its receptor are expressed in the male reproductive system. Initial studies have shown that erythropoietin affects the motility of spermatozoa. The aim of the present study was to investigate the in vitro effect of erythropoietin in the motility and vitality of human spermatozoa. Materials and Methods: Forty-three semen samples, obtained after 2-4 days of abstinence from sex, were analyzed and processed using density gradient centrifugation. Aliquots containing one million of spermatozoa were treated with either erythropoietin, at concentrations of 10 and 100 mIU/μl or standard culture medium for one hour. Results: Progressive motility and vitality of spermatozoa significantly increased following treatment with erythropoietin. The effect was not dosedependent. Conclusion: The supplementation of culture medium with erythropoietin improves sperm processing in terms of vitality and motility. Future research should focus on the effects of erythropoietin on sperm capacitation as well as on the signal transduction pathways activated by erythropoietin and its receptor in spermatozoa.

Cite

CITATION STYLE

APA

ASIMAKOPOULOS, B., TIPTIRI-KOURPETI, A., & METALINOU, C. (2021). Erythropoitein increases in vitro motility and vitality of human spermatozoa. In Vivo, 35(5), 2669–2673. https://doi.org/10.21873/INVIVO.12550

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free